Goserelin is a synthetic analogue of luteinizing hormone-releasing hormone (LHRH) used to treat hormone-sensitive cancers including prostate and breast cancer, as well as certain benign gynecological disorders. It is grouped under the following drug class(es): Antineoplastic agents, Hormones, LHRH analogues and Peptides. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Gosereline and Goserelina. Its PubChem CID is 5311128.
Goserelin
| CAS No | 65807-02-05 |
|---|---|
| Molecular Formula | C59H84N18O14 |
| Molecular Weight | 1269.4 g/mol |
| Synonyms | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Goserelin is a synthetic analogue of luteinizing hormone-releasing hormone (LHRH) used to treat hormone-sensitive cancers including prostate and breast cancer, as well as certain benign gynecological disorders.
The listed CAS number is 65807-02-05.
The listed molecular formula is C59H84N18O14.
The listed molecular weight is 1269.4 g/mol.
The source lists Gosereline and Goserelina.
It is listed under Antineoplastic agents, Hormones, LHRH analogues and Peptides.